News
Search EMA's news announcements
Pilots are part of ACT EU collaboration to foster high-quality clinical research in the EU.
EMA has issued recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2024.
14 new medicines recommended for approval; another seven medicines are recommended for extension of their therapeutic indications
Ixchiq was assessed under the OPEN framework to promote global public health.
Durveqtix received support through the PRIority Medicines (PRIME) scheme due to its potential to improve patients’ quality of life
EMA publishes 2023 annual report
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.
Question-and-answer document clarifies regulatory requirements for devices used in combination with medicines
EMA launches fifth communication perception survey